The Pillai Lab
Our research groups focuses on translational studies and novel diagnostic strategies for infectious pathogens including SARS-CoV-2, malaria, dengue, and C. difficile.
What Do We Work On?
Our laboratory integrates molecular, genomic, and proteomic approaches to unravel the pathogenesis of infectious agents, including Plasmodium falciparum, C. difficile, dengue, and SARS-CoV-2. We are dedicated to developing cutting-edge diagnostic tools, addressing antimicrobial resistance (AMR), and investigating the mechanisms behind drug and diagnostic resistance. By combining our scientific findings with clinical and epidemiological data, we aim to deepen our understanding of human disease and accelerate the translation of discoveries into impactful patient care.